To Get Full Access :

Litfulo

Litfulo is an oral treatment for adults and adolescents aged 12 and older with severe alopecia areata. It helps regrow scalp hair by blocking immune pathways that attack hair follicles.

The information outlined in the molecule details section below would help you evaluate Para IV filing opportunities early to secure a first-to-file advantage.

Molecule Details :

  • Molecule Name :

    Ritlecitinib
  • Innovator :

    PFIZER INC
  • Approval Date :

    23-Jun-23
  • NCE-1 Date :

    23-Jun-27
  • NCE Date :

    23-Jun-28
  • Dosage Form :

    Capsule
  • Strength :

    50MG
  • Therapeutic Category :

    Immunomodulators
  • Revenue ($M) :

    NA

Year-wise Projected Sales ($M) :

  • 2025 :

    113
  • 2026 :

    185
  • 2027 :

    264
  • 2028 :

    350
  • 2029 :

    423
  • 2030 :

    489
  • 2031 :

    540
Looking for this molecule for your next clinical research? Access regulatory-compliant comparators with assured timelines—delivered reliably through our global network.

Why Partner With Us

Login With

For full access Sign-up / Sign-in using below Methods:

By continuing, you agree to our Terms & Conditions and Privacy Policy. You can review them anytime.

Are you sure want to logout from NCE Grid?